ReviewBritish journal of pharmacology2008
Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective.
C E Pollard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papertrialcites it